U.S. flag

An official website of the United States government

NM_025215.6(PUS1):c.545-7C>T AND Myopathy, lactic acidosis, and sideroblastic anemia

Germline classification:
Benign (1 submission)
Last evaluated:
Dec 10, 2019
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001833522.9

Allele description [Variation Report for NM_025215.6(PUS1):c.545-7C>T]

NM_025215.6(PUS1):c.545-7C>T

Gene:
PUS1:pseudouridine synthase 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
12q24.33
Genomic location:
Preferred name:
NM_025215.6(PUS1):c.545-7C>T
HGVS:
  • NC_000012.12:g.131941285C>T
  • NG_013039.1:g.17086C>T
  • NM_001002019.3:c.461-7C>T
  • NM_001002020.3:c.461-7C>T
  • NM_025215.6:c.545-7C>TMANE SELECT
  • NC_000012.11:g.132425830C>T
  • NM_025215.5:c.545-7C>T
Links:
dbSNP: rs201541270
NCBI 1000 Genomes Browser:
rs201541270
Molecular consequence:
  • NM_001002019.3:c.461-7C>T - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001002020.3:c.461-7C>T - intron variant - [Sequence Ontology: SO:0001627]
  • NM_025215.6:c.545-7C>T - intron variant - [Sequence Ontology: SO:0001627]

Condition(s)

Name:
Myopathy, lactic acidosis, and sideroblastic anemia
Synonyms:
Mitochondrial myopathy and sideroblastic anemia; Myopathy with lactic acidosis and sideroblastic anemia
Identifiers:
MONDO: MONDO:0000863; MedGen: C1838103; Orphanet: 2598; OMIM: PS600462

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002091059Natera, Inc.
no assertion criteria provided
Benign
(Dec 10, 2019)
germlineclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Natera, Inc., SCV002091059.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024